To determine the role of PKM2 in tumour development promoted by APC mutation-induced Wnt/β-catenin signalling activation, we subcutaneously injected APC-mutated SW480 CRC cells stably expressing the control shRNA or PKM2 shRNA into nude mice. The gene discussed is PKM; the disease is colorectal carcinoma.